Skip to main content
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 1992 Dec;26(4):259–261. doi: 10.1136/bjsm.26.4.259

Dying to be big: a review of anabolic steroid use.

H M Perry 1, D Wright 1, B N Littlepage 1
PMCID: PMC1479009  PMID: 1490220

Abstract

Anabolic steroids use is commonly perceived to be the domain of the higher echelons of competitive athletes. However, a great deal of anabolic steroid use occurs in private gymnasia (non-local authority) among non-competitive recreational athletes. Our study has attempted to give an insight into the prevalence of the use of these drugs, the hazards associated with it, and the public health responses which we have adopted.

Full text

PDF
259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behrendt H., Boffin H. Myocardial cell lesions caused by an anabolic hormone. Cell Tissue Res. 1977 Jul 15;181(3):423–426. doi: 10.1007/BF00223116. [DOI] [PubMed] [Google Scholar]
  2. Buckley W. E., Yesalis C. E., 3rd, Friedl K. E., Anderson W. A., Streit A. L., Wright J. E. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988 Dec 16;260(23):3441–3445. [PubMed] [Google Scholar]
  3. Corder B. W., Dezelsky T. L., Toohey J. V., Tow P. K. An analysis of trends in drug use behavior at five American universities. J Sch Health. 1974 Sep;44(7):386–389. doi: 10.1111/j.1746-1561.1974.tb01934.x. [DOI] [PubMed] [Google Scholar]
  4. Haffner S. M., Kushwaha R. S., Foster D. M., Applebaum-Bowden D., Hazzard W. R. Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism. 1983 Apr;32(4):413–420. doi: 10.1016/0026-0495(83)90052-5. [DOI] [PubMed] [Google Scholar]
  5. Maron B. J., Roberts W. C., McAllister H. A., Rosing D. R., Epstein S. E. Sudden death in young athletes. Circulation. 1980 Aug;62(2):218–229. doi: 10.1161/01.cir.62.2.218. [DOI] [PubMed] [Google Scholar]
  6. Scott M. J., Scott M. J., Jr HIV infection associated with injections of anabolic steroids. JAMA. 1989 Jul 14;262(2):207–208. doi: 10.1001/jama.1989.03430020049017. [DOI] [PubMed] [Google Scholar]
  7. Sklarek H. M., Mantovani R. P., Erens E., Heisler D., Niederman M. S., Fein A. M. AIDS in a bodybuilder using anabolic steroids. N Engl J Med. 1984 Dec 27;311(26):1701–1701. doi: 10.1056/NEJM198412273112615. [DOI] [PubMed] [Google Scholar]
  8. Webb O. L., Laskarzewski P. M., Glueck C. J. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism. 1984 Nov;33(11):971–975. doi: 10.1016/0026-0495(84)90222-1. [DOI] [PubMed] [Google Scholar]
  9. Wilson J. D., Griffin J. E. The use and misuse of androgens. Metabolism. 1980 Dec;29(12):1278–1295. doi: 10.1016/0026-0495(80)90159-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES